Result entries:  6181
DRACP ID Peptide Name Sequence Sequence Length Origin
DRACP02875 LL-37 (17-29) [R23L] FKRIVQLIKDFLR 13 Synthetic
DRACP02876 LL-37 (17-29) [R23L]-Ac FKRIVQLIKDFLR 13 Synthetic
DRACP02877 LL-37 (17-29) [F27L] FKRIVQRIKDLLR 13 Synthetic
DRACP02878 LL-37 (17-29) [F27L]-Ac FKRIVQRIKDLLR 13 Synthetic
DRACP02879 LL-37 (17-29) [R23I,D26K] FKRIVQIIKKFLR 13 Synthetic
DRACP02880 LL-37 (17-29) [R23I,D26K]-Ac FKRIVQIIKKFLR 13 Synthetic
DRACP02881 LL-37 (17-29) [R23L,I24L,D26K,F27L] FKRIVQLLKKLLR 13 Synthetic
DRACP02882 LL-37 (17-29) [R23L,I24L,D26K,F27L]-Ac FKRIVQLLKKLLR 13 Synthetic
DRACP02883 LL-37 (17-29) [V21L] FKRILQRIKDFLR 13 Synthetic
DRACP02884 LL-37 (17-29) [V21L]-Ac FKRILQRIKDFLR 13 Synthetic
DRACP02885 CEN1 HC-Br GXFKKTFHKVSHAVKSGIHAGQRGCSALGF 30 Synthetic
DRACP02886 CEN1 HC GWFKKTFHKVSHAVKSGIHAGQRGCSALGF 30 Synthetic
DRACP02887 CEN1 HC (1–20) GWFKKTFHKVSHAVKSGIHA 20 Synthetic
DRACP02888 CEN1 HC (Ser) GWFKKTFHKVSHAVKSGIHAGQRGSSALGF 30 Synthetic
DRACP02889 H-2, Hymenochirin-1B [E6,N10 S5] IKLSPⓍTKDⓍLKKVLKGAIKGAIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02890 H-5, Hymenochirin-1B [A18,A22 S5] IKLSPETKDNLKKVLKGⓍIKGⓍIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02891 H-10, Hymenochirin-1B [E6,N10,A18,A22 S5] IKLSPⓍTKDⓍLKKVLKGⓍIKGⓍIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02892 H-14, Hymenochirin-1B [P5K, E6K, D9K] IKLSKKTKKNLKKVLKGAIKGAIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02893 H-15, Hymenochirin-1B [P5K; E6,N10 S5] IKLSKⓍTKDⓍLKKVLKGAIKGAIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02894 H-16, Hymenochirin-1B [D9K; E6,N10 S5] IKLSPⓍTKKⓍLKKVLKGAIKGAIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02895 H-17, Hymenochirin-1B [P5K,D9K; E6,N10 S5] IKLSKⓍTKKⓍLKKVLKGAIKGAIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02896 H-18, Hymenochirin-1B [P5K,E6K,D9K; A18,A22 S5] IKLSKKTKKNLKKVLKGⓍIKGⓍIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02897 H-19, Hymenochirin-1B [P5K,D9K; A18,A22 S5] IKLSKETKKNLKKVLKGAIKGⓍIAVⓍKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02898 H-20, Hymenochirin-1B [D9K;E6,N10,A18,A22 S5] IKLSPⓍTKKⓍLKKVLKGⓍIKGⓍIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02899 H-21, Hymenochirin-1B [P6K,D9K; E6,N10,A18,A22 S5] IKLSKⓍTKKⓍLKKVLKGⓍIKGⓍIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02900 H-57, Hymenochirin-1B [P5K,D9K; S4,T7,N10-GlcNAc; A18,A22 S5] IKLXKEXKKXLKKVLKGXIKGXIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02901 H-58, Hymenochirin-1B [P5K,E6K,D9K; S4,T7,N10-GlcNAc; A18,22 S5] IKLXKKXKKXLKKVLKGXIKGXIAVAKMV 29 Synthetic (Derived from Hymenochirin-1B)
DRACP02902 Dermaseptin S4 (1-26) ALWMTLLKKVLKAAAKAALNAVLVGA 26 Synthetic
DRACP02903 Dermaseptin S4 (1-24) ALWMTLLKKVLKAAAKAALNAVLV 24 Synthetic
DRACP02904 Dermaseptin S4 (1-22) ALWMTLLKKVLKAAAKAALNAV 22 Synthetic
<< < 87 88 89 90 91 >>

DRACP is developed by Dr.Zheng's team.